Found: 50
Select item for more details and to access through your institution.
Elafibranor: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 9, p. 1143, doi. 10.1007/s40265-024-02075-8
- By:
- Publication type:
- Article
Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 17, p. 1488, doi. 10.3390/cells13171488
- By:
- Publication type:
- Article
Thiazolidinediones: Understanding their role in diabetes management.
- Published in:
- African Journal of Diabetes Medicine, 2024, v. 32, n. 3, p. 9, doi. 10.54931/AJDM-32.3.4
- By:
- Publication type:
- Article
A natural PPAR-{gamma} agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 8, p. 2496, doi. 10.1093/ndt/gfn139
- By:
- Publication type:
- Article
Selective PPAR-Delta/PPAR-Gamma Activation Improves Cognition in a Model of Alzheimer's Disease.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1116, doi. 10.3390/cells12081116
- By:
- Publication type:
- Article
Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1412169
- By:
- Publication type:
- Article
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 9, p. 806, doi. 10.1111/j.1463-1326.2011.01411.x
- By:
- Publication type:
- Article
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy.
- Published in:
- Pediatric Nephrology, 2024, v. 39, n. 1, p. 309, doi. 10.1007/s00467-023-06088-5
- By:
- Publication type:
- Article
Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia.
- Published in:
- Nutrients, 2023, v. 15, n. 11, p. 2459, doi. 10.3390/nu15112459
- By:
- Publication type:
- Article
Shikonin Binds and Represses PPARγ Activity by Releasing Coactivators and Modulating Histone Methylation Codes.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1797, doi. 10.3390/nu15071797
- By:
- Publication type:
- Article
Convolvulus pluricaulis Choisy's Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1727, doi. 10.3390/nu15071727
- By:
- Publication type:
- Article
Selenium as a Factor Moderating Depression and Obesity in Middle-Aged Women.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1594, doi. 10.3390/nu15071594
- By:
- Publication type:
- Article
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.
- Published in:
- Chinese Medicine, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13020-023-00738-4
- By:
- Publication type:
- Article
The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function.
- Published in:
- Journal of Neuroinflammation, 2012, v. 9, n. 1, p. 63, doi. 10.1186/1742-2094-9-63
- Publication type:
- Article
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats.
- Published in:
- BMC Endocrine Disorders, 2011, v. 11, n. 1, p. 11, doi. 10.1186/1472-6823-11-11
- By:
- Publication type:
- Article
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)[alpha] agonist fenofibrate and the PPAR[gamma] agonist pioglitazone.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Sustained relief of trigeminal neuropathic pain by a blood-brain barrier penetrable PPAR gamma agonist.
- Published in:
- Molecular Pain, 2019, v. 15, p. 1, doi. 10.1177/1744806919884498
- By:
- Publication type:
- Article
Sustained relief of trigeminal neuropathic pain by a blood--brain barrier penetrable PPAR gamma agonist.
- Published in:
- Molecular Pain, 2019, v. 15, p. 1, doi. 10.1177/1744806919884498
- By:
- Publication type:
- Article
Novel therapeutic approaches in Cushing's disease: PPar-gamma agonists.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Novel Therapeutic Approaches in Cushing's Disease: PPar-Gamma Agonists.
- Published in:
- Turkish Journal of Endocrinology & Metabolism, 2009, v. 13, n. 4, p. 80
- By:
- Publication type:
- Article
PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy.
- Published in:
- Inflammation, 2012, v. 35, n. 1, p. 280, doi. 10.1007/s10753-011-9316-6
- By:
- Publication type:
- Article
Pioglitazone in spontaneous subarachnoid hemorrhage: study protocol of a multicenter, double-blind, randomized trial (PSSH).
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2023.1323292
- By:
- Publication type:
- Article
PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients .
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1220620
- By:
- Publication type:
- Article
Telmisartan-induced eNOS gene expression is partially independent of its PPAR-gamma agonist property.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Telmisartan-induced eNOS gene expression is partially independent of its PPAR-gamma agonist property.
- Published in:
- Clinical & Investigative Medicine, 2012, v. 35, n. 2, p. E55
- By:
- Publication type:
- Article
Microscopic image-based classification of adipocyte differentiation by machine learning.
- Published in:
- Histochemistry & Cell Biology, 2023, v. 159, n. 4, p. 313, doi. 10.1007/s00418-022-02168-z
- By:
- Publication type:
- Article
Low-Dose Chemotherapy in Combination with COX-2 Inhibitors and PPAR-Gamma Agonists in Recurrent High-Grade Gliomas – A Phase II Study.
- Published in:
- Oncology, 2007, v. 73, n. 1/2, p. 21, doi. 10.1159/000120028
- By:
- Publication type:
- Article
The role of Sgk-1 in the upregulation of transport proteins by PPAR-{gamma} agonists in human proximal tubule cells.
- Published in:
- Nephrology Dialysis Transplantation, 2009, v. 24, n. 4, p. 1130
- By:
- Publication type:
- Article
Anti-obesity effects of Lactiplantibacillus plantarum SKO-001 in high-fat diet-induced obese mice.
- Published in:
- European Journal of Nutrition, 2023, v. 62, n. 4, p. 1611, doi. 10.1007/s00394-023-03096-x
- By:
- Publication type:
- Article
Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat.
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2024, v. 35, n. 1/2, p. 45, doi. 10.1515/jbcpp-2023-0254
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Induces Regulatory T Cells in a Murine Model of Allergic Rhinitis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
PPAR Gamma agonists regulate tobacco smoke-induced toll like receptor 4 expression in alveolar macrophages.
- Published in:
- Respiratory Research, 2014, v. 15, n. 3, p. 1, doi. 10.1186/1465-9921-15-28
- By:
- Publication type:
- Article
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 4, p. 49, doi. 10.31838/ijpr/2020.12.04.012
- By:
- Publication type:
- Article
Novel PPAR-gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced-Fit Docking and Biological Assay Study.
- Published in:
- Chemical Biology & Drug Design, 2008, v. 71, n. 1, p. 57, doi. 10.1111/j.1747-0285.2007.00606.x
- By:
- Publication type:
- Article
Efficacy and Safety of Leriglitazone in Patients with Friedreich Ataxia.
- Published in:
- Neurology Alert, 2023, v. 42, n. 6, p. 1
- Publication type:
- Article
Exploring Rosiglitazone's Potential to Treat Alzheimer's Disease through the Modulation of Brain-Derived Neurotrophic Factor.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 7, p. 1042, doi. 10.3390/biology12071042
- By:
- Publication type:
- Article
PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients.
- Published in:
- PPAR Research, 2020, p. 1, doi. 10.1155/2020/4548012
- By:
- Publication type:
- Article
The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.
- Published in:
- PPAR Research, 2012, p. 1, doi. 10.1155/2012/929052
- By:
- Publication type:
- Article
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.
- Published in:
- PPAR Research, 2010, p. 1, doi. 10.1155/2010/325183
- By:
- Publication type:
- Article
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-[gamma] agonistic property.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
An L-Tyrosine Derivative and PPAR{gamma} Agonist, GW7845, Activates a Multifaceted Caspase Cascade in Bone Marrow B Cells.
- Published in:
- Toxicological Sciences, 2007, v. 98, n. 1, p. 125
- By:
- Publication type:
- Article
Effects of Peroxisome Proliferator-Activated Receptor-Gamma Agonists on Cognitive Function: A Systematic Review and Meta-Analysis.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 246, doi. 10.3390/biomedicines11020246
- By:
- Publication type:
- Article
Relationship of Mitochondrial-Related Protein Expression with the Differentiation, Metastasis, and Poor Prognosis of Oral Squamous Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4071, doi. 10.3390/cancers15164071
- By:
- Publication type:
- Article
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 2, p. 1, doi. 10.1016/j.aohep.2023.101182
- By:
- Publication type:
- Article
Autophagy modulation by PPAR-gamma agonists in obesity.
- Published in:
- Journal of Nutrition, Fasting & Health, 2022, v. 10, p. 272
- By:
- Publication type:
- Article
Advances in Mitochondria-Targeted Drug Delivery.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2089, doi. 10.3390/pharmaceutics15082089
- By:
- Publication type:
- Article
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 202, doi. 10.3390/pharmaceutics15010202
- By:
- Publication type:
- Article
Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonist (Pioglitazone) and Methotrexate on Disease Activity in Rheumatoid Arthritis (Experimental and Clinical Study).
- Published in:
- Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders, 2011, n. 4, p. 1, doi. 10.4137/CMAMD.S5951
- By:
- Publication type:
- Article
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone.
- Published in:
- Diabetology & Metabolic Syndrome, 2013, v. 5, n. 1, p. 1, doi. 10.1186/1758-5996-5-1
- By:
- Publication type:
- Article
PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.
- Published in:
- Addiction, 2017, v. 112, n. 10, p. 1861, doi. 10.1111/add.13868
- By:
- Publication type:
- Article